ArticleActa neuropathologica communications2025

Curative timed NK cell-based immunochemotherapy aborts brain tumour recurrence driven by mesenchymal glioma stem cells.

Brian Meehan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.